Get the app
US › Healthcare

NuCana PLC (NCNA)

US · Healthcare · Biotechnology

$0.99-2.94%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-3.1M
EPS
$-0.99

Key statistics

Market cap
$4.5M
P/E
0.0
Forward P/E
0.0
P/B
0.20
Book value
$6.22
EPS (TTM)
$0.00
52-week high
$6.10
52-week low
$0.95
50-day MA
$1.36
200-day MA
$1.92
Beta
2.31

Analyst view

with an average price target of $104.00.

Shareholding

Insiders
0.00%
Institutions
2.60%

Largest institutional holders

FundStake
StoneX Group Inc1.13%
Citadel Advisors Llc0.65%
HRT FINANCIAL LLC0.41%
Glass Jacobson Investment Advisors LLC0.36%
Rhumbline Advisers0.11%
Integrated Wealth Concepts LLC0.00%
Citigroup Inc0.00%
Caitong International Asset Management Co., Limited.0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NuCana PLC — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.